TY - JOUR
T1 - Risk factors associated with persistent postoperative hypertension in Cushing's syndrome
AU - Suzuki, T.
AU - Shibata, H.
AU - Ando, T.
AU - Kurihara, I.
AU - Kobayashi, S.
AU - Hayashi, K.
AU - Hayashi, M.
AU - Kawabe, H.
AU - Saito, I.
AU - Murai, M.
AU - Saruta, T.
N1 - Funding Information:
This work is supported by a Grant-in-Aid for Encouragement of Young Scientists (A), Scientific Research from Japan Society for the Promotion of Science (No. 12770620) to HShibata, and by a Grant-in-Aid for Research Projects for Disorders of Adrenocortical Hormone Production from the Ministry of Health and Welfare., Japan to T. Saruta. Correspondence should be addressed to: Hirotaka Shibata, M.D., Ph.D., Assistant Professor, Health Center and Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: hiro-405@cb3.so-net.ne.jp
PY - 2000
Y1 - 2000
N2 - The aim of the present study was to assess the long-term results of adrenalectomy and to evaluate potential risk factors for the persistence or recurrence of hypertension. Forty-five patients with Cushing's syndrome caused by benign cortisol-producing adrenocortical adenomas were evaluated before and for a period of 1 year after surgical cure. When the patients were classified into two groups according to whether their preoperative BP was more (HBP group) or less (NBP group) than 140/90 mmHg, the BP level was found to be continuously higher in the HBP group than in the NBP group during the year after surgery. This finding suggests that the preoperative BP level in Cushing's syndrome may be a determinant factor for persistent hypertension after surgery (P<0.05). In addition, a correlation was found between postoperative BP level and duration of hypertension (P<0.05), but no relationships were found between postoperative BP levels and other factors, including age, BMI, tumor size, serum cortisol, aldosterone, potassium, total cholesterol, or glucose levels. The above findings indicate that intensive control of preoperative BP to maintain it below 140/90 mmHg with antihypertensive medication is a very important means of improving prognosis for postoperative BP. Immediate diagnosis and surgical treatment to reduce the duration of hypertension are also crucial for the long-term BP prognosis.
AB - The aim of the present study was to assess the long-term results of adrenalectomy and to evaluate potential risk factors for the persistence or recurrence of hypertension. Forty-five patients with Cushing's syndrome caused by benign cortisol-producing adrenocortical adenomas were evaluated before and for a period of 1 year after surgical cure. When the patients were classified into two groups according to whether their preoperative BP was more (HBP group) or less (NBP group) than 140/90 mmHg, the BP level was found to be continuously higher in the HBP group than in the NBP group during the year after surgery. This finding suggests that the preoperative BP level in Cushing's syndrome may be a determinant factor for persistent hypertension after surgery (P<0.05). In addition, a correlation was found between postoperative BP level and duration of hypertension (P<0.05), but no relationships were found between postoperative BP levels and other factors, including age, BMI, tumor size, serum cortisol, aldosterone, potassium, total cholesterol, or glucose levels. The above findings indicate that intensive control of preoperative BP to maintain it below 140/90 mmHg with antihypertensive medication is a very important means of improving prognosis for postoperative BP. Immediate diagnosis and surgical treatment to reduce the duration of hypertension are also crucial for the long-term BP prognosis.
UR - http://www.scopus.com/inward/record.url?scp=0034524498&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034524498&partnerID=8YFLogxK
U2 - 10.3109/07435800009048601
DO - 10.3109/07435800009048601
M3 - Article
C2 - 11196456
AN - SCOPUS:0034524498
SN - 0743-5800
VL - 26
SP - 791
EP - 795
JO - Endocrine Research
JF - Endocrine Research
IS - 4
ER -